Previous close | 28.88 |
Open | 25.00 |
Bid | 26.22 x 1100 |
Ask | 26.25 x 1200 |
Day's range | 24.24 - 27.40 |
52-week range | 15.10 - 39.05 |
Volume | |
Avg. volume | 1,941,368 |
Market cap | 3.89B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.00 |
Earnings date | 28 Mar 2024 |
Forward dividend & yield | 1.00 (3.46%) |
Ex-dividend date | 23 Feb 2024 |
1y target est | 29.22 |
Chemours (CC) fourth-quarter earnings beat estimates, while sales miss despite growth across TT and TSS segments.
Shares of chemical maker Chemours are down in early trading Thursday after the company reported fourth-quarter results and provided an update about some of its recent accounting issues. Quarterly earnings were fine. Other things were weighing on investor sentiment.
Chemours' Adjusted Earnings Outpace Estimates Despite Tough Year